Cargando…
A Pilot Study of Lung Clearance Index as a Useful Outcome Marker in the Follow-Up of Pediatric Patients with Non-Cystic Fibrosis Bronchiectasis?
The forced expiratory volume in one second (FEV1) is regularly used for the follow-up of patients with non-cystic fibrosis bronchiectasis (nCF-BE). The lung clearance index (LCI), measured by the multiple breath washout test, has been recently proposed as a lung function measure and a potential tool...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217453/ https://www.ncbi.nlm.nih.gov/pubmed/37238339 http://dx.doi.org/10.3390/children10050791 |
_version_ | 1785048541570269184 |
---|---|
author | Alkoussa, Wael Hanssens, Laurence Sputael, Valerie De Lucia, Frederico Quentin, Christine |
author_facet | Alkoussa, Wael Hanssens, Laurence Sputael, Valerie De Lucia, Frederico Quentin, Christine |
author_sort | Alkoussa, Wael |
collection | PubMed |
description | The forced expiratory volume in one second (FEV1) is regularly used for the follow-up of patients with non-cystic fibrosis bronchiectasis (nCF-BE). The lung clearance index (LCI), measured by the multiple breath washout test, has been recently proposed as a lung function measure and a potential tool more sensitive than the FEV1 measured by spirometry in assessing airway changes seen on imaging. While several data have been endorsed as a useful endpoint in clinical trials of patients with early or mild CF lung disease and as the main outcome measure in clinical trials with CFTR modulators in children and adolescents with CF, few data are available in the context of non-CF bronchiectasis. The aim of this pilot study was to compare the LCI with the FEV1 as well as the forced vital capacity (FVC), the forced expiratory flow at 25–75% of the FVC (FEF 25–75%), and chest imaging based on the modified Reiff score in patients with primary ciliary dyskinesia (PCD) and non-CF, non-PCD bronchiectasis (PCD-BE and nCFnPCD-BE). Additionally, we compared each test’s duration and the preferred technique. Twenty children were included; nine had PCD-BE and eleven had nCFnPCD-BE. The median age was twelve years (ages ranging between five and eighteen years). The median LCI was seven while the median z-scores of the FEV1, FVC, and FEF 25–75% were −0.6, 0, and −0.9, respectively. No significant associations or correlations were observed between LCI, spirometric parameters, or the modified Reiff score. However, nearly half of the population (n = 9) had an abnormal LCI, while only 10% had an abnormal FEV1. A total of 75% of children preferred MBW, despite it lasting five times longer than spirometry. In this paper, the authors suggest that LCI might be useful in a cohort of pediatric patients with PCD-BE and nCFnPCD-BE for detecting early lung function changes during their follow-up. Additionally, MBW seems to be preferred by patients. These data may encourage further studies on this topic. |
format | Online Article Text |
id | pubmed-10217453 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102174532023-05-27 A Pilot Study of Lung Clearance Index as a Useful Outcome Marker in the Follow-Up of Pediatric Patients with Non-Cystic Fibrosis Bronchiectasis? Alkoussa, Wael Hanssens, Laurence Sputael, Valerie De Lucia, Frederico Quentin, Christine Children (Basel) Article The forced expiratory volume in one second (FEV1) is regularly used for the follow-up of patients with non-cystic fibrosis bronchiectasis (nCF-BE). The lung clearance index (LCI), measured by the multiple breath washout test, has been recently proposed as a lung function measure and a potential tool more sensitive than the FEV1 measured by spirometry in assessing airway changes seen on imaging. While several data have been endorsed as a useful endpoint in clinical trials of patients with early or mild CF lung disease and as the main outcome measure in clinical trials with CFTR modulators in children and adolescents with CF, few data are available in the context of non-CF bronchiectasis. The aim of this pilot study was to compare the LCI with the FEV1 as well as the forced vital capacity (FVC), the forced expiratory flow at 25–75% of the FVC (FEF 25–75%), and chest imaging based on the modified Reiff score in patients with primary ciliary dyskinesia (PCD) and non-CF, non-PCD bronchiectasis (PCD-BE and nCFnPCD-BE). Additionally, we compared each test’s duration and the preferred technique. Twenty children were included; nine had PCD-BE and eleven had nCFnPCD-BE. The median age was twelve years (ages ranging between five and eighteen years). The median LCI was seven while the median z-scores of the FEV1, FVC, and FEF 25–75% were −0.6, 0, and −0.9, respectively. No significant associations or correlations were observed between LCI, spirometric parameters, or the modified Reiff score. However, nearly half of the population (n = 9) had an abnormal LCI, while only 10% had an abnormal FEV1. A total of 75% of children preferred MBW, despite it lasting five times longer than spirometry. In this paper, the authors suggest that LCI might be useful in a cohort of pediatric patients with PCD-BE and nCFnPCD-BE for detecting early lung function changes during their follow-up. Additionally, MBW seems to be preferred by patients. These data may encourage further studies on this topic. MDPI 2023-04-27 /pmc/articles/PMC10217453/ /pubmed/37238339 http://dx.doi.org/10.3390/children10050791 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Alkoussa, Wael Hanssens, Laurence Sputael, Valerie De Lucia, Frederico Quentin, Christine A Pilot Study of Lung Clearance Index as a Useful Outcome Marker in the Follow-Up of Pediatric Patients with Non-Cystic Fibrosis Bronchiectasis? |
title | A Pilot Study of Lung Clearance Index as a Useful Outcome Marker in the Follow-Up of Pediatric Patients with Non-Cystic Fibrosis Bronchiectasis? |
title_full | A Pilot Study of Lung Clearance Index as a Useful Outcome Marker in the Follow-Up of Pediatric Patients with Non-Cystic Fibrosis Bronchiectasis? |
title_fullStr | A Pilot Study of Lung Clearance Index as a Useful Outcome Marker in the Follow-Up of Pediatric Patients with Non-Cystic Fibrosis Bronchiectasis? |
title_full_unstemmed | A Pilot Study of Lung Clearance Index as a Useful Outcome Marker in the Follow-Up of Pediatric Patients with Non-Cystic Fibrosis Bronchiectasis? |
title_short | A Pilot Study of Lung Clearance Index as a Useful Outcome Marker in the Follow-Up of Pediatric Patients with Non-Cystic Fibrosis Bronchiectasis? |
title_sort | pilot study of lung clearance index as a useful outcome marker in the follow-up of pediatric patients with non-cystic fibrosis bronchiectasis? |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217453/ https://www.ncbi.nlm.nih.gov/pubmed/37238339 http://dx.doi.org/10.3390/children10050791 |
work_keys_str_mv | AT alkoussawael apilotstudyoflungclearanceindexasausefuloutcomemarkerinthefollowupofpediatricpatientswithnoncysticfibrosisbronchiectasis AT hanssenslaurence apilotstudyoflungclearanceindexasausefuloutcomemarkerinthefollowupofpediatricpatientswithnoncysticfibrosisbronchiectasis AT sputaelvalerie apilotstudyoflungclearanceindexasausefuloutcomemarkerinthefollowupofpediatricpatientswithnoncysticfibrosisbronchiectasis AT deluciafrederico apilotstudyoflungclearanceindexasausefuloutcomemarkerinthefollowupofpediatricpatientswithnoncysticfibrosisbronchiectasis AT quentinchristine apilotstudyoflungclearanceindexasausefuloutcomemarkerinthefollowupofpediatricpatientswithnoncysticfibrosisbronchiectasis AT alkoussawael pilotstudyoflungclearanceindexasausefuloutcomemarkerinthefollowupofpediatricpatientswithnoncysticfibrosisbronchiectasis AT hanssenslaurence pilotstudyoflungclearanceindexasausefuloutcomemarkerinthefollowupofpediatricpatientswithnoncysticfibrosisbronchiectasis AT sputaelvalerie pilotstudyoflungclearanceindexasausefuloutcomemarkerinthefollowupofpediatricpatientswithnoncysticfibrosisbronchiectasis AT deluciafrederico pilotstudyoflungclearanceindexasausefuloutcomemarkerinthefollowupofpediatricpatientswithnoncysticfibrosisbronchiectasis AT quentinchristine pilotstudyoflungclearanceindexasausefuloutcomemarkerinthefollowupofpediatricpatientswithnoncysticfibrosisbronchiectasis |